Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 769 of 1,261

  1. US 8952067

    Subcutaneous fat reduction

    Atheronova Operations, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  2. US 8951501

    Noninvasive thermometry monitoring system

    UNITED ARAB EMIRATES UNIVERSITY · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  3. US 8952065

    Acetylcysteine composition and uses thereof

    Cumberland Pharmaceuticals Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  4. US 8951504

    (trimethoxyphenylamino) pyrimidinyl formulations

    Rigel Pharmaceuticals, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  5. US 8952129

    Method of treating degenerative diseases

    The Board of Regents of the University of Texas System · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  6. US 8952050

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  7. US 8952049

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  8. US 8952169

    N-substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  9. WO 2015016729

    COMPOSÉS D'URÉE ET LEUR UTILISATION COMME INHIBITEURS DE L'ENZYME FAAH

    BIAL PORTELA & Cª S A [PT] · Granted Feb 5, 2015 · Expires Jan 31, 2035

    granted

  10. US 2015038439

    METHOD FOR PREPARING SUSPENSIONS OF LOW-SOLUBILITY MATERIALS

    MACLEOD STEVEN K [US] · Granted Feb 5, 2015 · Expires Jan 31, 2035

    granted

  11. WO 2015016728

    COMPOSÉS D'URÉE ET LEUR UTILISATION COMME INHIBITEURS DE L'ENZYME FAAH

    BIAL PORTELA & Cª S A [PT] · Granted Feb 5, 2015 · Expires Jan 31, 2035

    granted

  12. CA 2919844

    COMPOSES D'UREE ET LEUR UTILISATION COMME INHIBITEURS DE L'ENZYME FAAH

    BIAL PORTELA & CA SA [PT] · Granted Feb 5, 2015 · Expires Jan 31, 2035

    granted

  13. US 8945858

    Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

    The Regents of the University of California · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  14. US 8946444

    Tetrahydrocarbazoles as active agents for inhibiting VEGF production by translational control

    PTC THERAPEUTICS, INC. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  15. US 8946409

    Polycyclic β lactam derivatives for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  16. US 8946300

    Use of rasagilline for the treatment of restless legs syndrome

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  17. US 8946382

    Apelin peptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  18. US 8946271

    Water soluble furoxan derivatives having antitumor activity

    HUMANITAS MIRASOLE S.P.A. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  19. US 8946205

    1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

    Addex Pharma, S.A. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  20. US 8945559

    Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  21. US 8946172

    Method for reducing scarring during wound healing using antisense compounds directed to CTGF

    Northwestern University · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  22. US 8945604

    Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication

    The Regents of the University of California · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  23. US 8945508

    Dendrimer compositions and methods of synthesis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  24. US 8945544

    Immunogenic compositions comprising progastrin and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.